67713-99-9Relevant articles and documents
Synthesis of 3H-[1]Benzofuro[2,3-b]imidazo[4,5-f]quinolines as New Fluorescent Heterocyclic Systems for Dye-Sensitized Solar Cells
Sadeghzadeh,Pordel,Davoodnia
, p. 440 - 447 (2021/04/13)
Abstract: One-pot reaction of 1-alkyl-5-nitro-1H-benzimidazoles with 2-(1-benzofuran-3-yl)acetonitrile in methanol in the presence of potassium hydroxide gave 3H-[1]benzofuro[2,3-b]imidazo[4,5-f]quinolines as high-performance organic photosensitizers belonging to a new fluorescent heterocyclic system. The structure of the new compounds was assigned on the basis of their spectral and analytical data. Study of the optical properties of the title compounds revealed their interesting photophysical properties such as high fluorescence quantum yields. Their electrochemical properties were studied by cyclic voltammetry, and reversible oxidation waves were observed. The photovoltaic performance of the fluorescent heterocyclic compounds was estimated at 4.89–5.05% from the IPCE spectra and I–V curves.
Boronic acid derivatives
-
, (2021/07/21)
The present invention relates to boronic acid derivatives; the present invention provides compounds of formula (I) or pharmaceutically acceptable salts, solvates, polymorphs or isomers thereof, pharmaceutical compositions comprising these compounds, and uses of such compounds in the treatment of lmp7-related diseases.
IMMUNOPROTEASOME INHIBITORS
-
, (2019/06/13)
Provided herein are compounds, such as a compound of Formula (I), or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
